Form 8-A12G - Registration of securities [Section 12(g)]:
SEC Accession No. 0001493152-23-007173
Filing Date
2023-03-10
Accepted
2023-03-10 08:30:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 form8a12g.htm 8-A12G 43869
2 ex3-1.htm EX-3.1 32212
  Complete submission text file 0001493152-23-007173.txt   77134
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12G | Act: 34 | File No.: 000-55092 | Film No.: 23721706
SIC: 2834 Pharmaceutical Preparations